• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TOWER研究中接受因卡波糖毒素A治疗的肢体痉挛患者的目标分析。

Goal analysis in patients with limb spasticity treated with incobotulinumtoxinA in the TOWER study.

作者信息

Fheodoroff Klemens, Scheschonka Astrid, Wissel Jörg

机构信息

Department of Neurorehabilitation, Gailtal-Klinik Hermagor, Hermagor, Austria.

Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany.

出版信息

Disabil Rehabil. 2022 Apr;44(8):1367-1373. doi: 10.1080/09638288.2020.1804627. Epub 2020 Aug 17.

DOI:10.1080/09638288.2020.1804627
PMID:32805151
Abstract

PURPOSE

To map spasticity-related goals using the International Classification of Functioning, Disability and Health (ICF) linking rules, and review goal syntax to direct future goal setting.

MATERIALS AND METHODS

1633 treatment goals, set during the TOWER study, were linked to the ICF framework and EQ-5D domains. Goals were mapped independently by two investigators with expertise in ICF linking rules.

RESULTS

In total, 1630 (99.8%) goals could be mapped to the ICF (inter-rater agreement on the main ICF category 96.1%). Most goals (80.2%) were mapped to a single ICF category and were related to activities/participation (54.9%). 170 (10.4%) goals were related to general tasks and activities, such as positioning, stretching, and strengthening. In total, 1072 goals (65.6%) mapped to the EQ-5D domains (inter-rater agreement 90.8%). Analysis of the goal syntax highlighted the need to include a verb in patient-centered goals to direct active behavior.

CONCLUSIONS

The ICF offers a broad framework for setting patient-centered, easily understandable goals for patients with spasticity, including goals related to (guided) self-management activities. This analysis sheds new light on patient needs and could direct future goal-driven botulinum toxin spasticity treatment focused on enabling patients to better manage activity limitations imposed by their body function impairments. NCT01603459 registered with ClinicalTrials.gov (https://clinicaltrials.gov/ct2/show/NCT01603459).Implications for RehabilitationThe ICF offers a broad framework for setting patient-centered, easily understandable goals for patients with spasticity.ICF domains that include general tasks and demands can be used to establish goals relating to (guided) self-management of spasticity.An ICF-based goal-setting framework may increase the comparability of clinical data across studies.

摘要

目的

运用《国际功能、残疾和健康分类》(ICF)关联规则来梳理与痉挛相关的目标,并审视目标句法以指导未来的目标设定。

材料与方法

在TOWER研究期间设定的1633个治疗目标与ICF框架及EQ-5D领域进行了关联。由两名精通ICF关联规则的研究人员独立对目标进行映射。

结果

总计1630个(99.8%)目标可映射至ICF(在主要ICF类别上的评分者间一致性为96.1%)。大多数目标(80.2%)映射至单一ICF类别,且与活动/参与相关(54.9%)。170个(10.4%)目标与一般任务和活动相关,如体位摆放、伸展和强化训练。总计1072个目标(65.6%)映射至EQ-5D领域(评分者间一致性为90.8%)。对目标句法的分析突出表明,以患者为中心的目标中需要包含一个动词来指导积极行为。

结论

ICF为为痉挛患者设定以患者为中心、易于理解的目标提供了一个广泛框架,包括与(引导式)自我管理活动相关的目标。该分析揭示了患者需求的新情况,并可指导未来以目标为导向的肉毒杆菌毒素治疗痉挛,重点是使患者能够更好地应对因身体功能障碍所导致的活动受限。在ClinicalTrials.gov(https://clinicaltrials.gov/ct2/show/NCT01603459)注册,编号为NCT01603459。

对康复的启示

ICF为为痉挛患者设定以患者为中心、易于理解的目标提供了一个广泛框架。

包括一般任务和要求的ICF领域可用于确立与痉挛(引导式)自我管理相关的目标。

基于ICF的目标设定框架可能会提高各研究间临床数据的可比性。

相似文献

1
Goal analysis in patients with limb spasticity treated with incobotulinumtoxinA in the TOWER study.TOWER研究中接受因卡波糖毒素A治疗的肢体痉挛患者的目标分析。
Disabil Rehabil. 2022 Apr;44(8):1367-1373. doi: 10.1080/09638288.2020.1804627. Epub 2020 Aug 17.
2
Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?上肢注射肉毒杆菌毒素A后的目标达成情况:我们是否在促进以客户为中心的目标的实现?
J Rehabil Med. 2014 Oct;46(9):864-8. doi: 10.2340/16501977-1853.
3
Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.中风后上肢痉挛个体的目标达成量表
Occup Ther Int. 2016 Dec;23(4):379-389. doi: 10.1002/oti.1440. Epub 2016 Oct 3.
4
Use of the International Classification of Functioning, Disability and Health to support goal-setting practices in pediatric rehabilitation: a rapid review of the literature.运用《国际功能、残疾和健康分类》支持儿科康复中的目标设定实践:文献快速回顾。
Disabil Rehabil. 2021 Mar;43(6):884-894. doi: 10.1080/09638288.2019.1643419. Epub 2019 Jul 25.
5
Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.在接受A型肉毒毒素治疗的非行走型脑瘫儿童和青少年群体中,使用《国际功能、残疾和健康分类》制定目标清单。
BMC Pediatr. 2018 Jan 4;18(1):1. doi: 10.1186/s12887-017-0974-x.
6
BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.BoTULS 研究:一项多中心随机对照试验,旨在评估 A 型肉毒毒素治疗脑卒中后上肢痉挛的临床疗效和成本效益。
Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.
7
Compiling standardized information from clinical practice: using content analysis and ICF Linking Rules in a goal-oriented youth rehabilitation program.从临床实践中编纂标准化信息:在以目标为导向的青年康复计划中使用内容分析和国际功能、残疾和健康分类链接规则。
Disabil Rehabil. 2019 Mar;41(5):613-621. doi: 10.1080/09638288.2017.1380718. Epub 2017 Sep 23.
8
[Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].[包括重复注射A型肉毒杆菌毒素(BoNT-A)在内的上肢痉挛综合管理对现实生活中以患者为中心的目标达成情况的影响:俄罗斯亚人群前瞻性观察性上肢国际痉挛队列研究(ULIS-III)的结果]
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):39-48. doi: 10.17116/jnevro202112111139.
9
Goals Set by Patients Using the Model before Receiving Botulinum Injections and Their Relation to Spasticity Distribution.患者在接受肉毒杆菌注射前使用该模型设定的目标及其与痉挛分布的关系。
Physiother Can. 2017;69(2):113-119. doi: 10.3138/ptc.2016-25.
10
Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA.上肢和下肢痉挛患者接受依库珠单抗毒素 A 治疗后的生活质量。
Health Qual Life Outcomes. 2020 Mar 4;18(1):51. doi: 10.1186/s12955-020-01304-4.

引用本文的文献

1
Post-Stroke Spastic Movement Disorder and Botulinum Toxin A Therapy: Early Detection And Early Injection.中风后痉挛性运动障碍与A型肉毒毒素治疗:早期检测与早期注射
Ann Rehabil Med. 2023 Oct;47(5):326-336. doi: 10.5535/arm.23108. Epub 2023 Oct 23.
2
Person-centered goal setting is feasible in people with Parkinson's disease who have subjective cognitive decline: a mixed methods study.以患者为中心的目标设定在有主观认知下降的帕金森病患者中是可行的:一项混合方法研究。
Disabil Rehabil. 2023 Jan;45(1):90-97. doi: 10.1080/09638288.2022.2025930. Epub 2022 Jan 13.
3
European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A.
欧洲专家共识:改善鞘内注射巴氯芬和/或肉毒毒素 A 治疗致残性痉挛患者选择的方法。
J Rehabil Med. 2022 Jan 3;54:jrm00241. doi: 10.2340/16501977-2877.